Zdrowie i gospodarka · 22/07/2022
FDA Announces Draft Guidance for Real-Time Oncology Review Process
The FDA is releasing a draft guidance document outlining the process for submitting new drug and biologics applications with cancer indications for review under its Real-Time Oncology Review program.